Benefits and Risks of Pharmacological Agents Used for the Treatment of Menorrhagia
This review compares the efficacy and tolerability of various medical treatments for menorrhagia, finding tranexamic acid and mefenamic acid most effective, while acknowledging limitations of other drugs and the need for further research.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (96)
- A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia via openalex
- A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia via openalex
- A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia via openalex
- An Objective Evaluation of Flurbiprofen and Tranexamic Acid in the Treatment of Idiopathic Menorrhagia via openalex
- Assessment of medical treatments for menorrhagia via openalex
- Choice of treatment for menor rhagia via openalex
- Comparison between mefenamic acid and danazol in the treatment of established menorrhagia via openalex
- Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid via openalex
- Danazol for heavy menstrual bleeding via openalex
- Danazol inhibition of steroidogenesis in the human corpus luteum. via openalex
- Danazol in menorrhagia: a double blind placebo controlled trial via openalex
- Danazol in the Treatment of Menorrhagia: The Effect of a 1 Month Induction Dose (200 mg) and 2 Month's Maintenance Therapy (200 mg, 100 mg, 50 mg or placebo) via openalex
- Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
- Gestrinone in the treatment of menorrhagia via openalex
- Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia via openalex
- Management of Cyclical Menorrhagia with Prostaglandin Synthetase Inhibitor via openalex
- Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder. via openalex
- Medical management of menorrhagia via openalex
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding via openalex
- Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study via openalex
- Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of Menorrhagia via openalex
- REDUCTION OF MENSTRUAL BLOOD LOSS BY DANAZOL IN UNEXPLAINED MENORRHAGIA: LACK OF EFFECT OF PLACEBO via openalex
- REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex
- Risk-Benefit Assessment of Drugs Used for the Treatment of Menstrual Disorders via openalex
- THE EFFECT OF DANAZOL ON MENORRHAGIA, COAGULATION MECHANISMS, HAEMATOLOGICAL INDICES AND BODY WEIGHT via openalex
- The effects of danazol mefanamic acid, norethistherone and a progesterone-impragnated coil on endometrial prostaglandin concentrations in women with monorrhagia via openalex
- Treating Menorrhagia in Primary Care: <i>An Overview of Drug Trials and a Survey of Prescribing Practice</i> via openalex
- Treatment of menorrhagia with intrauterine release of progesterone via openalex
- Use of a super active luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia via openalex
- Zoladex® (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy via openalex
- W2011783339 via openalex
- W2012165536 via openalex
- W2012911358 via openalex
- W2018000086 via openalex
- W2020529016 via openalex
- W2021738675 via openalex
- W2031785143 via openalex
- W2036894361 via openalex
- W2037729051 via openalex
- W2041637524 via openalex
- W2046921112 via openalex
- W2056752342 via openalex
- W2059406869 via openalex
- W2063032334 via openalex
- W2065614931 via openalex
- W2069642788 via openalex
- W2072195133 via openalex
- W2075276906 via openalex
- W2077556384 via openalex
- W2085217616 via openalex
- W2086126831 via openalex
- W2091560484 via openalex
- W2091692603 via openalex
- W2096468388 via openalex
- W2096824429 via openalex
- W2098230593 via openalex
- W2101146672 via openalex
- W2104668417 via openalex
- W2120835813 via openalex
- W2124686676 via openalex
- W2152367884 via openalex
- W2181409682 via openalex
- W2284230695 via openalex
- W2418241203 via openalex
- W2473786944 via openalex
- W3125434660 via openalex
- W3135185800 via openalex
- W63062164 via openalex
- W103343754 via openalex
- W139498877 via openalex
- W191591924 via openalex
- W1529006820 via openalex
- W1548171782 via openalex
- W1553057436 via openalex
- W1573603557 via openalex
- W1593235060 via openalex
- W1783602832 via openalex
- W1827577161 via openalex
- W1852631630 via openalex
- W1907235146 via openalex
- W1955491160 via openalex
- W1957638663 via openalex
- W1968761932 via openalex
- W1970623458 via openalex
- W1971184127 via openalex
- W1977848946 via openalex
- W1979137115 via openalex
- W1981616577 via openalex
- W1983060435 via openalex
- W1983356056 via openalex
- W1983557162 via openalex
- W1988697850 via openalex
- W1992206173 via openalex
- W2000210781 via openalex
- W2003865723 via openalex
- W2006665319 via openalex
Cited by (16)
- CURRENT STATE OF THE PROBLEM OF MENSTRUAL CYCLE DISORDERS IN WOMEN OF REPRODUCTIVE AGE WITH UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA (LITERATURE REVIEW) 2024
- Benign Uterine Diseases 2019
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2019
- Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy 2014
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2013
- Heavy menstrual flow: current and future trends in management. 2013
- Cost Burden and Treatment Patterns Associated with Management of Heavy Menstrual Bleeding 2012
- Management of Menorrhagia Associated with Chemotherapy‐Induced Thrombocytopenia in Women with Hematologic Malignancy 2011
- Endometriosis in the Adolescent Patient 2011
- Common problems in pediatric and adolescent gynecology 2010
- Dysfunctional uterine bleeding: from adolescence to menopause 2010
- Endometrial bleeding 2007
- Prevention of severe menorrhagia in oncology patients with treatment‐induced thrombocytopenia by luteinizing hormone‐releasing hormone agonist and depo‐medroxyprogesterone acetate 2006
- Medical management of menorrhagia 2005
- 10.1016/s1885-9070(09)36011-4 2000
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding 1998
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00